Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy. [electronic resource]
Producer: 20201221Description: e014328 p. digitalISSN:- 2047-9980
- Aged
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Cardiovascular Diseases -- mortality
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Female
- Glycated Hemoglobin -- metabolism
- Glycemic Control
- Heart Disease Risk Factors
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypoglycemic Agents -- therapeutic use
- Male
- Middle Aged
- Predictive Value of Tests
- Prospective Studies
- Risk Assessment
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.